Skip to content
The ACTC-DS repository is under review for potential modification in compliance with Administration directives.
Home
About Us
Alzheimer’s in Down Syndrome
Trials
Sites
News
Contact Us
Submit Proposal
Amyloid-lowering immunotherapies for Alzheimer disease: current status and future directions
Written by
in
Publication
←
Down syndrome and Alzheimer’s disease: insights into biomarkers, clinical symptoms, and pathology
Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome
→
More posts
